Literature DB >> 21384627

[Giant cell peripheral granuloma surrounding a dental implant: case report].

Lore Hanselaer1, Jan Cosyn, Hilde Browaeys, Hugo De Bruyn.   

Abstract

BACKGROUND: The rising number of dental implants placed in the treatment of partial or full edentulism confronts the clinician with more implant-related pathology. The presence of a transmucosal component resembles the natural tooth and makes it likewise prone to oral plaque adhesion and plaque-related diseases. However, non-plaque-related diseases can also occur around implants. CASE: This clinical case describes the historical background, the diagnosis, treatment and follow-up of a 33-year-old female patient presenting with a peripheral giant cell granuloma surrounding a maxillary implant. Diagnosis was established by histopathologic analysis. The treatment consisted of complete excision and bone curettage, strict plaque-control and intensive aftercare. Eight months later, no recurrence had been observed. Nevertheless, the soft tissues did not return exactly to their original situation.
CONCLUSIONS: Early diagnosis by means of a biopsy is crucial when an epulis is detected. This results in both a less invasive excision and a more favorable aesthetic outcome.

Entities:  

Mesh:

Year:  2010        PMID: 21384627

Source DB:  PubMed          Journal:  Rev Belge Med Dent (1984)        ISSN: 0775-0293


  3 in total

1.  Clinical Management of a Peri-Implant Giant Cell Granuloma.

Authors:  A Pacifici; D Carbone; R Marini; G L Sfasciotti; L Pacifici
Journal:  Case Rep Dent       Date:  2015-12-14

Review 2.  Pyogenic Granuloma/Peripheral Giant-Cell Granuloma Associated with Implants.

Authors:  Enric Jané-Salas; Rui Albuquerque; Aura Font-Muñoz; Beatríz González-Navarro; Albert Estrugo Devesa; Jose López-López
Journal:  Int J Dent       Date:  2015-12-01

3.  KRAS Mutation in an Implant-associated Peripheral Giant Cell Granuloma of the Jaw: Implications of Genetic Analysis of the Lesion for Treatment Concept and Surveillance.

Authors:  Reinhard E Friedrich; Falk WÜsthoff; Andreas M Luebke; Felix K Kohlrusch; Ilse Wieland; Martin Zenker; Martin Gosau
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.406

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.